Meanings of co-morbid condition in anglès

Poorest HRQoL was found in patients with more than one co-morbid condition.

The current trial will evaluate a short-term structured protocol which targets a co-morbid condition often considered of primary importance by service users.

At least one co-morbid condition was present in 94% of the sample patients, with cardiovascular disease and diabetes being the most frequently encountered disorders (58%).

Neither co-morbid conditions nor the location of abscesses affected the outcome of drainage.

Age, ethnicity and gender influence the type of co-morbid conditions.

Many have co-morbid conditions with an underlying thread of inflammation.

Of all co-morbid conditions, musculoskeletal disorders were most strongly associated with poor general HRQoL.

Conclusion: These results suggest a high prevalence of co-morbid conditions in severely obese patients undergoing bariatric surgery.

Women-centred interventions aimed at decreasing HIV incidence in young African women need to address these common co-morbid conditions.

One role was providing obesity management to patients who had co-morbid conditions and were seen regularly in chronic disease clinics.

Background: Gastric bypass is a proven treatment option for weight loss and the reduction of medical co-morbid conditions in the obese population.

Objectives: As the HIV-infected population ages, the role of cellular senescence and inflammation on co-morbid conditions and pharmacotherapy is increasingly of interest.

Adjusted hazard ratios for study outcomes were calculated using Cox proportional hazards models after adjustment for the effects of demographics and co-morbid conditions.

Results: The prevalence of many co-morbid conditions and the total number of co-morbid conditions correlate highly with increasing age, increasing BMI, and male gender.

Prevention, early diagnosis and treatment of co-morbid conditions and the complications of chronic kidney disease may improve the survival of patients with transplant failure.

Survival of destination therapy patients is somewhat inferior to the survival of bridge-to-transplant patients, in part due to their co-morbid conditions which limit life expectancy.